Austin, Texas, Dec. 20, 2025 (GLOBE NEWSWIRE) -- Elastography Imaging Market Size & Growth Analysis:
According to SNS Insider, the Elastography Imaging Market size was valued at USD 3.27 billion in 2024 and is projected to reach USD 5.88 billion by 2032, growing at a CAGR of 7.66% over the forecast period of 2025–2032.
The increasing demand for non-invasive diagnostic procedures, particularly for liver fibrosis, oncology, and musculoskeletal disorders, is significantly contributing to market growth. Elastography imaging provides quantitative and qualitative assessment of tissue stiffness, enabling early disease detection and improved clinical decision-making.
Get a Sample Report of Elastography Imaging Market: https://www.snsinsider.com/sample-request/8316
The U.S. Elastography Imaging Market was valued at USD 1.04 billion in 2024 and is projected to reach USD 1.84 billion by 2032, growing at a CAGR of 7.47% from 2025–2032. Strong healthcare infrastructure, high adoption of advanced imaging technologies, and increasing screening for chronic liver diseases are key factors supporting market expansion in the U.S.
Major Players Analysis Listed in this Report are:
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
- Samsung Medison
- Hitachi
- Shenzhen Mindray
- Bio-Medical Electronics
- FUJIFILM Holdings
- Resoundant Inc.
- Other key players
Elastography Imaging Market Report Scope
| Report Attributes | Details |
| Market Size in 2024 | USD 3.27 billion |
| Market Size by 2032 | USD 5.88 billion |
| CAGR | CAGR of 7.66% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Segmentation Analysis:
By Modality
Ultrasound represents the dominant segment in the elastography imaging market, with a 70.52% market share in 2024 as elastography imaging is cheaper, portable, and easier to use than other imaging tools such as MR elastography. MRI plays a very important role in the elastography imaging market growth as it is the fastest-growing segment with a CAGR of 8.03%. Magnetic Resonance Imaging (MRI) is the fastest-growing segment in the elastography market as it provides very high diagnostic accuracy and non-invasive deep organ exploration not easily accessible to ultrasonography.
By Application
In 2024, the General Imaging segment dominated the elastography imaging market share with a 34.80%. General imaging rules over the market of elastography imaging as it can be performed on different body organs, including the liver, thyroid, breast, kidneys, and other soft tissues, and is versatile and always clinically in demand. Breast elastography is expected to witness the fastest growth during the forecast period as it enables early, accurate, and non-invasive diagnosis of breast tumors through the measurement of tissue stiffness.
By End-User
Hospitals are the largest and fastest growing market of the elastography imaging market, with 41.30% of market share and the CAGR of 8.05% as they have well-established facilities, large patient quotas, and the capacity to implement new medical innovations.
Need Any Customization Research on Elastography Imaging Market, Enquire Now: https://www.snsinsider.com/enquiry/8316
Key Elastography Imaging Market Segments
By modality
- Ultrasound
- MRI
By application
- General Imaging
- Hepatology
- Breast
- Urology
- Cardiology
- Orthopedic and Musculoskeletal
- Others
By End-user
- Hospitals
- Imaging Centers
- Others
Regional Insights:
In 2024, the North American region dominated the elastography imaging market and accounted for 38.52% of the overall revenue share. North America dominates the market of elastography imaging, primarily due to the developed health care system with widespread access to novel imaging technologies and high prevalence of chronic diseases.
The Asia Pacific region is projected to grow with the fastest CAGR of 8.10% over the forecast period. The elastography imaging market in APAC is expected to grow at the highest CAGR during the forecast period, owing to a large population, including a large patient population due to the high prevalence of chronic diseases such as liver diseases, cancer, and diabetes.
Recent Developments:
- In early 2024, Resoundant expanded MR Elastography clinical collaborations. Resoundant partnered with academic hospitals in the U.S. and Europe to expand MR elastography use in brain and liver diagnostics.
- In March 2025, Siemens announced enhanced AI-assisted elastography analysis integrated into its ACUSON Sequoia system, improving real-time liver fibrosis staging. The new AI tools offer automated quantification for improved workflow in large-volume hospital settings.
Purchase Single User PDF of Elastography Imaging Market Report (20% Discount): https://www.snsinsider.com/checkout/8316
Exclusive Sections of the Report (The USPs):
- DISEASE INCIDENCE & PREVALENCE METRICS – helps you understand the 2024 burden of liver, breast, thyroid, and musculoskeletal disorders driving elastography imaging demand across key regions.
- REGIONAL PRESCRIPTION & DIAGNOSTIC UTILIZATION TRENDS – helps you analyze 2024 prescription patterns by region, highlighting physician adoption rates and shifts toward non-invasive diagnostic imaging.
- DEVICE VOLUME & INSTALLATION FORECASTS – helps you track elastography device volumes by region from 2024–2032, identifying high-growth geographies and long-term capacity requirements.
- HEALTHCARE SPENDING ALLOCATION ANALYSIS – helps you assess regional healthcare expenditure split across government, commercial, private, and out-of-pocket spending influencing imaging adoption.
- ACCESSIBILITY & REIMBURSEMENT DRIVEN DEMAND – helps you evaluate how public funding levels and private insurance coverage affect patient access and utilization of elastography imaging services.
- REGIONAL MARKET ATTRACTIVENESS INDEX – helps you combine disease burden, prescription trends, device volumes, and healthcare spending to identify the most lucrative and underserved markets.
Access Complete Report Details of Elastography Imaging Market Analysis & Outlook: https://www.snsinsider.com/reports/elastography-imaging-market-8316
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
